Infant Formula With Added Alpha-Lactalbumin Improves Nighttime Feeding Patterns With Implications for Sleep Quality
Diana Orenstein1, Devon Kuehn1, Andrea Knezevic2
1ByHeart, Inc, New York, New York, USA.
Objective:
Sleep is crucial during infancy and supports health and development. Tryptophan is influential in the sleep/wake cycle, and studies have shown that increasing tryptophan intake can improve sleep outcomes. Consumption of alpha-lactalbumin increases ratios of tryptophan to large neutral amino acids (LNAA), an indicator of brain concentrations associated with sleep latency. The objective was to evaluate whether an infant formula with added alpha-lactalbumin improves sleep quality, indicated by nighttime feeding patterns.
Method:
Healthy infants born at full term were randomized to study formula (SF) with added alpha-lactalbumin or a formula with identical protein content without added alpha-lactalbumin (CF). Feeding patterns were assessed over 24 weeks and serum amino acids were measured at week 16. Groups were compared using repeated-measures mixed models and Wilcoxon rank-sum test, and the relationship between feeding and amino acid concentrations was assessed with correlation analysis.
Results:
In 128 infants, mean time between nighttime feeds differed between the groups over time on study (p = 0.03) At 16 weeks, mean time between nighttime feeds was greater (+32 min; 95% confidence interval [CI], 5-60; p = 0.02), and mean number of nighttime feeds was lower (-0.3; 95% CI: -0.6 to 0.0; p = 0.04) in the SF group. Tryptophan concentrations (96 ± 15 μmol/L vs 86 ± 17 μmol/L, p = 0.019) and the ratio of tryptophan to LNAA (0.146 ± 0.026 vs 0.130 ± 0.018; p = 0.007) were higher in the SF subgroup.
Conclusions:
Clinically relevant longer duration between nighttime feeds was observed in infants in the SF group throughout most of the study, with an average of 32 additional minutes at 16 weeks. Concurrently, infants in the SF group had a higher tryptophan:LNAA ratio, supporting the hypothesis that the addition of alpha-lactalbumin may have positively impacted outcomes associated with sleep quality.
Trial Registration:
www.clinicaltrials.gov (NCT04218929 and NCT04389606 January 6, 2020, and May 15, 2020, respectively).
Related Concept Videos
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Stages of Sleep
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
Nightmares and Night Terrors
Nightmares often...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...

